TG Therapeutics, Inc.
IT ˙ BIT ˙ US88322Q1085
34,00 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1TGTX / TG Therapeutics, Inc.
InstitutionWalleye Trading LLC
Latest Disclosed Ownership5,386 shares
Latest Disclosed Value $ 178,923
Walleye Trading LLC ownership in 1TGTX / TG Therapeutics, Inc.

On May 8, 2026 - Walleye Trading LLC filed a 13F-HR form disclosing ownership of 5,386 shares of TG Therapeutics, Inc. (IT:1TGTX) valued at $148,977 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 36,541 shares of TG Therapeutics, Inc.. This represents a change in shares of -85.26% during the quarter. The current value of the position is $183,124 USD.

Walleye Trading LLC has a history of taking positions in derivatives of the underlying security (1TGTX) in the form of stock options. The firm currently holds call options representing 46,600 of underlying shares valued at $1,548,052 USD and put options representing 12,800 of underlying shares valued at $425,216 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1TGTX / TG Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F TG THERAPEUTICS COM 88322Q108 5,386 -31,155 -85.26 179 -83.65 0.0003
2026-02-13 2025-12-31 13F TG THERAPEUTICS COM 88322Q108 36,541 9,320 34.24 1,089 10.78 0.0016
2025-11-14 2025-09-30 13F TG THERAPEUTICS COM 88322Q108 27,221 11,617 74.45 983 75.22 0.0015
2025-08-13 2025-06-30 13F TG THERAPEUTICS COM 88322Q108 15,604 -1,599 -9.29 562 -17.26 0.0010
2025-05-14 2025-03-31 13F TG THERAPEUTICS COM 88322Q108 17,203 -8,888 -34.07 678 -13.63 0.0016
2025-02-13 2024-12-31 13F TG THERAPEUTICS COM 88322Q108 26,091 13,564 108.28 785 167.92 0.0017
2024-11-14 2024-09-30 13F TG THERAPEUTICS COM 88322Q108 12,527 6,490 107.50 293 173.83 0.0006
2024-08-14 2024-06-30 13F TG THERAPEUTICS COM 88322Q108 6,037 3,121 107.03 107 143.18 0.0003
2024-05-15 2024-03-31 13F TG THERAPEUTICS COM 88322Q108 2,916 -25,873 -89.87 44 -91.04 0.0001
2024-02-14 2023-12-31 13F TG THERAPEUTICS COM 88322Q108 28,789 19,254 201.93 492 521.52 0.0011
2023-11-21 2023-09-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 9,535 7,206 309.40 80 38.60 0.0002
2023-11-14 2023-09-30 13F TG THERAPEUTICS COM 88322Q108 9,535 7,206 80 0.0002
2023-08-14 2023-06-30 13F TG THERAPEUTICS COM 88322Q108 2,329 2,329 58 0.0002
2023-05-15 2023-03-31 13F TG THERAPEUTICS COM 88322Q108 0 -18,049 -100.00 0 -100.00
2023-02-14 2022-12-31 13F TG THERAPEUTICS COM 88322Q108 18,049 18,049 214 0.0006
2022-11-14 2022-09-30 13F TG THERAPEUTICS COM 88322Q108 0 -5,122 -100.00 0 -100.00
2022-08-08 2022-06-30 13F TG THERAPEUTICS COM 88322Q108 5,122 5,122 22 0.0001
2021-05-17 2021-03-31 13F TG THERAPEUTICS COM 88322Q108 0 -1,691 -100.00 0 -100.00
2021-02-16 2020-12-31 13F TG THERAPEUTICS COM 88322Q108 1,691 1,691 88 0.0004
2020-05-15 2020-03-31 13F TG THERAPEUTICS COM 88322Q108 0 -13,900 -100.00 0 -100.00
2020-02-14 2019-12-31 13F TG THERAPEUTICS COM 88322Q108 13,900 13,900 154 0.0011
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-08 2026-03-31 13F TG THERAPEUTICS COM Call 46,600 298.29 1,548 344.83 n/a n/a n/a
2026-02-13 2025-12-31 13F TG THERAPEUTICS COM Call 11,700 -47.53 349 -56.77 n/a n/a n/a
2025-11-14 2025-09-30 13F TG THERAPEUTICS COM Call 22,300 -65.85 806 -65.74 n/a n/a n/a
2025-08-13 2025-06-30 13F TG THERAPEUTICS COM Call 65,300 41.04 2,350 28.77 n/a n/a n/a
2025-05-14 2025-03-31 13F TG THERAPEUTICS COM Call 46,300 -21.92 1,826 2.30 n/a n/a n/a
2025-02-13 2024-12-31 13F TG THERAPEUTICS COM Call 59,300 118.01 1,785 180.50 n/a n/a n/a
2024-11-14 2024-09-30 13F TG THERAPEUTICS COM Call 27,200 85.03 636 143.68 n/a n/a n/a
2024-08-14 2024-06-30 13F TG THERAPEUTICS COM Call 14,700 -23.83 262 -10.92 n/a n/a n/a
2024-05-15 2024-03-31 13F TG THERAPEUTICS COM Call 19,300 -28.52 294 -36.44 n/a n/a n/a
2024-02-14 2023-12-31 13F TG THERAPEUTICS COM Call 27,000 10.66 461 127.09 n/a n/a n/a
2023-11-21 2023-09-30 13F/A TG THERAPEUTICS COM Call 24,400 70.63 204 -42.82 n/a n/a n/a
2023-11-14 2023-09-30 13F TG THERAPEUTICS COM Call 24,400 204 n/a n/a n/a
2023-08-14 2023-06-30 13F TG THERAPEUTICS COM Call 14,300 -39.92 355 -0.56 n/a n/a n/a
2023-05-15 2023-03-31 13F TG THERAPEUTICS COM Call 23,800 73.72 358 120.37 n/a n/a n/a
2023-02-14 2022-12-31 13F TG THERAPEUTICS COM Call 13,700 -77.90 162 -55.86 n/a n/a n/a
2022-11-14 2022-09-30 13F TG THERAPEUTICS COM Call 62,000 287.50 367 439.71 n/a n/a n/a
2022-08-08 2022-06-30 13F TG THERAPEUTICS COM Call 16,000 68 n/a n/a n/a
2022-05-16 2022-03-31 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F TG THERAPEUTICS COM Call 11,600 28.89 220 -26.67 n/a n/a n/a
2021-11-15 2021-09-30 13F TG THERAPEUTICS COM Call 9,000 119.51 300 88.68 n/a n/a n/a
2021-08-16 2021-06-30 13F TG THERAPEUTICS COM Call 4,100 159 n/a n/a n/a
2021-05-17 2021-03-31 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F TG THERAPEUTICS COM Call 7,500 390 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-08 2026-03-31 13F TG THERAPEUTICS COM Put 12,800 -60.37 425 -55.82 n/a n/a n/a
2026-02-13 2025-12-31 13F TG THERAPEUTICS COM Put 32,300 -47.31 963 -56.55 n/a n/a n/a
2025-11-14 2025-09-30 13F TG THERAPEUTICS COM Put 61,300 -5.40 2,214 -5.06 n/a n/a n/a
2025-08-13 2025-06-30 13F TG THERAPEUTICS COM Put 64,800 21.35 2,332 10.78 n/a n/a n/a
2025-05-14 2025-03-31 13F TG THERAPEUTICS COM Put 53,400 -0.19 2,106 30.75 n/a n/a n/a
2025-02-13 2024-12-31 13F TG THERAPEUTICS COM Put 53,500 32.75 1,610 70.91 n/a n/a n/a
2024-11-14 2024-09-30 13F TG THERAPEUTICS COM Put 40,300 247.41 943 357.28 n/a n/a n/a
2024-08-14 2024-06-30 13F TG THERAPEUTICS COM Put 11,600 26.09 206 48.20 n/a n/a n/a
2024-05-15 2024-03-31 13F TG THERAPEUTICS COM Put 9,200 46.03 140 29.91 n/a n/a n/a
2024-02-14 2023-12-31 13F TG THERAPEUTICS COM Put 6,300 -73.86 108 -46.77 n/a n/a n/a
2023-11-21 2023-09-30 13F/A TG THERAPEUTICS COM Put 24,100 26.84 201 -57.32 n/a n/a n/a
2023-11-14 2023-09-30 13F TG THERAPEUTICS COM Put 24,100 201 n/a n/a n/a
2023-08-14 2023-06-30 13F TG THERAPEUTICS COM Put 19,000 134.57 472 289.26 n/a n/a n/a
2023-05-15 2023-03-31 13F TG THERAPEUTICS COM Put 8,100 -78.17 122 -72.37 n/a n/a n/a
2023-02-14 2022-12-31 13F TG THERAPEUTICS COM Put 37,100 -14.52 439 70.43 n/a n/a n/a
2022-11-14 2022-09-30 13F TG THERAPEUTICS COM Put 43,400 1.64 257 41.99 n/a n/a n/a
2022-08-08 2022-06-30 13F TG THERAPEUTICS COM Put 42,700 181 n/a n/a n/a
2022-05-16 2022-03-31 13F TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F TG THERAPEUTICS COM Put 7,100 31.48 135 -25.00 n/a n/a n/a
2021-11-15 2021-09-30 13F TG THERAPEUTICS COM Put 5,400 -25.00 180 -35.48 n/a n/a n/a
2021-08-16 2021-06-30 13F TG THERAPEUTICS COM Put 7,200 279 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.